Filho Alberto Soares Pereira, Soares Júnior José Maria, Arkader Jacob, Maciel Gustavo Arantes Rosa, Baracat Edmund C
Santa Casa da Misericórdia do Rio de Janeiro, 28a Enfermaria, Rua Dr. Diogo de Faria, 1087--conjunto 61004037-003, São Paulo, SP, Brazil.
Maturitas. 2005 Jun 16;51(2):146-53. doi: 10.1016/j.maturitas.2004.06.018.
The aim of this study was to investigate the attitudes and practices of Brazilian female gynecologists surrounding their personal use of menopausal/postmenopausal hormone therapy (HT).
This study was conducted in February 2001 using a mail survey. Three thousand eighty nine (n = 3089) female gynecologists over the age of 35 years and affiliated with the Brazilian Federation of Obstetricians and Gynecologists (FEBRASGO) were sent a questionnaire inquiring about their demographic, professional, medical, and behavioral background as well as their personal use of HT.
The response rate was 56.3%. Information on the menopausal status was available for 1655 respondents: 755 (45.7%) were postmenopausal, 172 indicated that they had irregular menses cycles (9.2%), and 728 (44.1%) underwent regular menses. Approximately, 47% of the postmenopausal respondents had been subject to a hysterectomy and were above the age of 50 years or had undergone bilateral oophorectomy. When asked about personal HT use, 61.1% and 10.3% of the respondents indicated that they were current or former users, respectively. 28.6% of the respondents had never used HT. The highest frequency of use occurred during their fifth decade. The main reasons for their use of HT included the attenuation of vasomotor symptoms, the prevention/treatment of osteoporosis, or the prevention of cardiovascular disease. Combined estrogen/progestin therapy was the preferred choice for postmenopausal gynecologists with an intact uterus. Family or personal histories of breast cancer or smoking were reported as deterrents against HT use for the female gynecologists.
Brazilian postmenopausal gynecologists engage in a high frequency of HT use. High levels of personal use may influence the general population towards HT prescription and compliance.
本研究旨在调查巴西女性妇科医生在个人使用绝经/绝经后激素疗法（HT）方面的态度和做法。
本研究于2001年2月通过邮件调查进行。向3089名年龄在35岁以上、隶属于巴西妇产科医生联合会（FEBRASGO）的女性妇科医生发送了一份问卷，询问她们的人口统计学、专业、医疗和行为背景以及她们个人使用HT的情况。
回复率为56.3%。1655名受访者提供了绝经状态信息：755人（45.7%）已绝经，172人表示月经周期不规律（9.2%），728人（44.1%）月经规律。大约47%的绝经后受访者接受了子宫切除术，年龄在50岁以上或接受了双侧卵巢切除术。当被问及个人使用HT的情况时，61.1%和10.3%的受访者分别表示她们是当前使用者或曾经使用者。28.6%的受访者从未使用过HT。使用频率最高的时期是她们的五十多岁。她们使用HT的主要原因包括缓解血管舒缩症状、预防/治疗骨质疏松症或预防心血管疾病。对于子宫完整的绝经后妇科医生来说，雌激素/孕激素联合疗法是首选。乳腺癌家族史或个人史以及吸烟被报告为女性妇科医生使用HT的阻碍因素。
巴西绝经后妇科医生HT使用频率较高。较高的个人使用率可能会影响普通人群对HT的处方和依从性。
